The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer.
about
Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell modelSR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer.Strategic role of selected noble metal nanoparticles in medicine.Fungi as an efficient mycosystem for the synthesis of metal nanoparticles: progress and key aspects of research.Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
P2860
The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The potential role of nanotech ...... triple negative breast cancer.
@en
The potential role of nanotech ...... triple negative breast cancer.
@nl
type
label
The potential role of nanotech ...... triple negative breast cancer.
@en
The potential role of nanotech ...... triple negative breast cancer.
@nl
prefLabel
The potential role of nanotech ...... triple negative breast cancer.
@en
The potential role of nanotech ...... triple negative breast cancer.
@nl
P2093
P2860
P1433
P1476
The potential role of nanotech ...... triple negative breast cancer.
@en
P2093
Andras G Lacko
Nirupama Sabnis
Rebecca Johnson
Walter J McConathy
P2860
P304
P356
10.3390/PHARMACEUTICS5020353
P577
2013-01-01T00:00:00Z